Navigation Links
Shire plc: IFRS Results for the Year Ending December 31, 2007
Date:3/25/2008

10 567.0 565.0

Investing activities

Movement in restricted cash (9.7) 0.7

Purchase of subsidiary undertaking, net of

cash and cash equivalents acquired (2,458.6) (0.8)

Expenses relating to the New River acquisition (61.0) -

Loan repaid by ID Biomedical Corporation (IDB) - 70.6

Purchase of property, plant and equipment (PP&E) (93.7) (68.7)

Purchase of intangible assets (223.0) (173.6)

Purchase of available-for-sale financial

assets (63.2) (9.8)

Net decrease in current financial assets 55.8 6.9

Proceeds/deposits received from sale of

product rights 234.4 63.4

Proceeds from sale of PP&E 0.8 3.4

Proceeds from sale of available-for-sale

financial assets 0.5 -

Interest received 52.5 47.2

Dividend received from associates 2.3 0.4

Dividend from joint venture 6.8 5.8

__________ __________

Net cash used in investing activities (2,556.1) (54.5)

__________ __________

Financing activities

Proceeds from issue of Shire 2.75% convertible

bonds due 2014 8 1,100.0 -

Redemption of New River 3.75% convertible

notes due 2013 (279.4) -

Redemption of 2% guaranteed convertible loan

notes 2011 -
'/>"/>

SOURCE Shire plc
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33

Related biology technology :

1. Shire plc: Excellent Performance Across All Areas of the Business and Accelerating New Product Sales Drive Revenue Growth of 36%
2. Shire plc: Correction Re Website
3. Shires ELAPRASE(R) (idursulfase) Approved in Mexico for Treatment of Hunter Syndrome
4. Shire Engages Palio
5. Texas Boy Receives Wheelchair From New Hampshire Couples Recently Deceased Granddaughter
6. FDA Approves Additional Dosage Strengths of Shires ADHD Treatment VYVANSE(TM) (lisdexamfetamine dimesylate) Which May Help Physicians Tailor Treatment for Individual Patients
7. Shire Expands its Gastrointestinal Portfolio Through In-Licensing Celiac Disease Phase 2 Product From Alba Therapeutics Corporation
8. Alba Therapeutics Corporation and Shire plc Enter Into $325 Million ex-US, ex-Japan Licensing Agreement to Develop and Commercialize AT-1001
9. Shire plc: Board Changes
10. David Mott Appointed Non Executive Director at Shire
11. Correction: Shire plc: Third Quarter 2007 results date notification November 1, 2007
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/19/2014)... BURLINGTON, Mass. , Dec. 19, 2014 ... biomaterial market will grow at a 12 percent compound ... a result of the aging population and the increasing ... Latin America will also spur demand ... results of dental implant and periodontal treatments. ...
(Date:12/19/2014)... LayerBio is an MIT spin-off developing novel drug ... Eye Institute (NEI) at the National Institutes of Health ... to develop a drug-eluting intraocular lens (IOL) for cataract ... vision loss in people over age 40 and the ... Mandell, LayerBio’s Founder and CEO, "There is a critical ...
(Date:12/19/2014)... (PRWEB) December 19, 2014 In contrast ... of LEDs with various colors, Valoya uses proprietary LED ... This offers best possible uniformity which is critical in ... and high spectral accuracy throughout its lifetime which is ... LED tubes. , "The investment cost was clearly ...
(Date:12/19/2014)... Egenix, Inc. is pleased to announce that Lionel Goldfrank ... succeed Donald Fresne ; Mr. Fresne has also resigned ... of the Board.  In recognition of the many contributions and ... twenty years, the Board designated Mr. Fresne as Chairman Emeritus. ... Search Committee to find a suitable replacement with Biotech industry ...
Breaking Biology Technology:Latin American Dental Biomaterial Market Will Expand at a 12 Percent Annual Growth Rate Through 2023 2Latin American Dental Biomaterial Market Will Expand at a 12 Percent Annual Growth Rate Through 2023 3LayerBio Awarded NIH Grant to Develop a Drug Delivery Device for Cataract Surgery 2
... Calif., March 18 Ingenuity Systems, the,leading ... researchers, has,announced that they have extended and ... access to Ingenuity Pathways Analysis,(IPA) software. The ... access to researchers for rapid assessment of ...
... Therapeutics, Inc.,(CTI) (Nasdaq: CTIC ; MTAX) management will present at the 7th ... in the Bay Auditorium of the Bell Harbor Conference Center., The presentation ... The webcast can be accessed at, http://www.celltherapeutics.com ., ... WBBA Invest Northwest Conference ...
... Nadrian Seeman has received the American Chemical Societys Nicholas ... structural DNA nanotechnology. Created in 1902, the Nichols Medal ... and is given by the societys New York section. ... of Chemistry at NYU, founded and developed the field ...
Cached Biology Technology:Ingenuity Systems Extends Enterprise-Level Software Agreement With GlaxoSmithKline 2
(Date:12/11/2014)... Research and Markets , ... http://www.researchandmarkets.com/research/9ql3kr/biometrics_market ) has announced the addition of the ... to their offering. One major ... of multimodal biometric systems. Multimodal biometric systems utilize ... verification and identification purposes. This helps to reduce ...
(Date:12/10/2014)... N.C. , Dec. 9, 2014  Valencell, a ... it is seeing a staggering demand from its licensees ... the Company revealed, is not solely coming from fitness ... as well. "A wearable is only as ... result, accuracy is the ultimate driver in long-term mass ...
(Date:12/10/2014)... December 9, 2014   ... Platform   Jifflenow, ... scheduling solutions for business-to-business (B2B) events, today announced ... in mobile near-field communication (NFC), Bluetooth low energy ... (Logo: http://photos.prnewswire.com/prnh/20140612/691055) , Jifflenow will integrate ...
Breaking Biology News(10 mins):Biometrics Market in India 2015-2019: Key Vendors are 3M Cogent, NEC, Safran and Suprema 2Wearable Technology Products Demand Highly Accurate Biometric Technology 2Jifflenow And ITN International Bring Cutting-Edge Badge Scanning Technology To B2B Events 2Jifflenow And ITN International Bring Cutting-Edge Badge Scanning Technology To B2B Events 3
... College Park, MD (June 17, 2010) -- An understanding ... essential in fields as diverse as drug delivery, cellular ... the soil. When a driving force is applied, displacement ... in the Journal of Chemical Physics , which ...
... that alcohol use in pregnancy can lead to children ... study fetal alcohol syndrome (FAS) have not made definitive ... effectively treating it, say researchers from Georgetown University Medical ... Neuroscience , four first-year medical students at Georgetown ...
... the important role that a key protein plays in ... greater understanding of stem cells. Timothy L. Megraw, ... outlined his findings in the cover story of the ... article, "CDK5RAP2 Regulates Centriole Engagement and Cohesion in Mice," ...
Cached Biology News:Little is understood about alcohol's effect on fetal development, Georgetown researchers say 2Little is understood about alcohol's effect on fetal development, Georgetown researchers say 3Florida State researcher uncovers protein's role in cell division 2
Caliper offers a wide array of standard LabChip products designed to be used in combination with our AMS 90 and LabChip 3000 microfluidic platforms....
Caliper offers a wide array of standard LabChip products designed to be used in combination with our AMS 90 and LabChip 3000 microfluidic platforms....
Experion Pro260 chips are the microfluidic chips used to perform protein analysis with the Experion automated electrophoresis system. Each chip has the capacity to run 10 protein samples. Supplied as...
Caliper offers a wide array of standard LabChip products designed to be used in combination with our AMS 90 and LabChip 3000 microfluidic platforms....
Biology Products: